TMPRSS2 and atrial fibrillation: Experimental data show the potential actions of propolis against viral targets such as TMPRSS2, ACE2 receptor and PAK1, which justifies the experimental use of EPP-AF and results in new perspectives to treat diseases that lead to immuno-inflammatory dysregulation6,11.